At a glance
ClinicalIndex Comparison RecordN/ACompleted· 96 enrolled
Drug / intervention
Olive oildietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Enteral Olive Oil Supplement On Weight Gain, Length of Hospital Stay, And Development of Some Complications in Very Low Birth-Weight Infants: A Randomized Controlled Study
In Brief
A clinical study evaluating Olive oil for Olive Oil Adverse Reaction and 3 related conditions. Completed, enrolled 96 participants across 1 site.
Detailed Summary
Objective: The objective of the present research is to compare the nutritional status, weight gain, length of hospital stay, and development of some complications in very low birth-weight (VLBW) infants who received and did not receive olive oil supplementation enterally.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOlive Oil Adverse Reaction, Nursing Caries, Enteral and Supplement Feeds Adverse Reaction, Preterm
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
Primary CompletionMar 2021
Study CompletionAug 2021
First PostedApr 2023
TodayJul 2026
First PostedApr 18, 2023
Enrollment StartJun 1, 2020
Primary CompletionMar 1, 2021
Study CompletionAug 1, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.2 years ago
Interventions
Olive oildietary
0.5 cc/30 ml of olive oil (a brand easily available in the markets) was added to the milk at each feeding of the infants in the intervention group